Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-30

Clinical Trial Update: A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating PRT-201 in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRT-201

Snippet

Sponsor: Proteon Therapeutics | Conditions: Chronic Kidney Disease | Phase 1, Phase 2 | Status: COMPLETED